U.S. market Closed. Opens in 12 hours 14 minutes

CLBTW | Cellebrite DI Ltd. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue325.11M270.65M246.25M194.91M171.85M
Cost of Revenue53.23M50.75M42.56M37.88M35.82M
Gross Profit271.88M219.91M203.69M157.03M136.03M
Operating Expenses238.60M218.86M189.87M147.82M137.55M
Selling, General & Admin154.21M138.24M124.33M91.17M90.23M
Research & Development84.39M80.62M65.54M54.38M46.57M
Other Operating ExpensesN/AN/AN/A2.27M750.00K
Operating Income33.28M1.04M13.82M9.22M-1.33M
Other Expenses / Income-108.84M119.72M68.48M2.18M2.75M
Before Tax Income-75.56M120.76M82.31M11.40M1.42M
Income Tax Expenses5.54M-45.00K10.91M5.62M3.29M
Net Income-81.10M120.81M71.40M5.78M-1.88M
Interest Expenses753.00K119.72M564.00K1.42MN/A
Basic Shares Outstanding190.15M182.69M144.00M123.70M187.17M
Diluted Shares Outstanding190.15M195.39M161.54M123.70M187.17M
EBITDA43.29M10.24M20.91M15.54M2.75M
EBITDA Margin13.32%3.78%8.49%7.97%1.60%
EBIT-74.81M240.48M82.87M12.82M1.42M
EBIT Margin-23.01%88.85%33.65%6.58%0.82%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙